The largest database of trusted experimental protocols

2 protocols using g007 lk

1

Cell Viability Assay: Tankyrase and PARP Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTT assays were performed to quantify the viability of the cells following treatment with G007-LK (MedChemExpress: Cat. No. HY-12438), a tankyrase inhibitor, and Olaparib (LC Laboratories, Cat. No. O-9201), a poly(ADP-ribose) polymerase inhibitor. H58 cells were seeded into 96-well plates at a concentration of 5000 cells per well and left to attach overnight at 37˚C and 5% CO2. G007-LK was then added to the culture medium to a final concentration of 0, 0.1, 0.5, 1, 2, 4 μmol/L. Olaparib was then added to the culture medium to a final concentration of 0, 1, 5, 10, 20, 40 μmol/L. After 96 hours, MTT (Thermo Fisher Scientific, Cat. No. M6494) was added to the culture media, and the cells were incubated for 4h at 37 ˚C. The culture media was then removed and the formazan crystals in the cells were solubilized using dimethyl sulfoxide (Sigma-Aldrich, Cat. No. 472301), with plate agitation for 10 min. Absorbance at 490 nm was the measure using a Bio-Rad Xmark Microplate Spectrophotometry (Bio-Rad, Hercules, California, USA).
+ Open protocol
+ Expand
2

Chemical Compounds Acquisition and Handling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Simmiparib was synthesized at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Olaparib, G007‐LK, VE‐821, chloroquine, losmapimod, RBN‐2397, cisplatin, and LY3214996 were purchased from MedChemExpress (NJ, USA). Talazoparib, veliparib, irinotecan, and rucaparib were purchased from Selleck Chemicals (Shanghai, China). All drugs were dissolved in DMSO and stored at −20°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!